A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination with Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants with HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer. Here, ERBB2 is linked to gastric cancer.